Investor Presentaiton

HORIZONTALLY DIVERSIFIED Scientific Leadership Advantage Industry Leading Science & Innovation Team to Drive Medical Advancements Jon Page, PhD Chief Science Officer First scientist to sequence the cannabis genome and provide deep insights into the biosynthesis of cannabinoids Jason Dyck, PhD Human Scientist, Director Professor in the Department of Pediatrics at the University of Alberta and a Canada Research Chair in Molecular Medicine 40 Clinical Studies Underway or Completed"> 7 Pre-Clinical Studies in Progress 27 Clinical Studies Currently Under Discussion VERTICALLY INTEGRATED Kelly Narine, PhD Head of Biomedical Research PhD in Medical Genetics from the University of Alberta; Deep expertise in translating research into positive health outcomes Shane Morris, PhD Head of Product Development Experienced executive in the cannabis industry since 2015; previously part of the senior leadership team at Hydropothecary With Strong IP Retention on Clinical Studies Clinical Research Areas include. Pain, Epilepsy, PTSD, Anxiety. Opioid Sparing, Cancer, Neurodegeneration Canada MRC CMRC UNIVERSITY OF TORONTO McGill UNIVERSITY Partnering with Leading Institutions and Universities UNIVERSITY IVERSITY OF OF MANITOBA UBC THE UNIVERSITY OF BRITISH COLUMBIA 1. Studies include randomized clinical trials and observational studies in addition to several case studies.. UNIVERSITY OF SASKATCHEWAN Mount Sinai Hospital Sinai Health System Joseph & Wolf Lebovic Health Complex camh Centre for Addiction and Mental Health ser mental Mater Ce AURORA 22

View entire presentation